Ledger.Open graph →
SEC Form D · filed August 24, 2022

GELESIS HOLDINGS, INC

Offering
$50.6M
Sold
$576K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Alison L. Bauerlein · BOSTON, MADirectorRaju L. Kucherlapati · BOSTON, MADirectorPaul L. Fonteyne · BOSTON, MADirectorElliot L. Maltz · BOSTON, MAExecDavid L. Abraham · BOSTON, MAExecAlessandro L. Sannino · BOSTON, MAExecJane L. Wildman · BOSTON, MADirectorDavid Pass · BOSTON, MAExecElaine L. Chiquette · BOSTON, MAExecHarry L. Leider · BOSTON, MAExecDominic L. Perks · BOSTON, MADirectorKathryn L. Cavanaugh · BOSTON, MADirectorYishai Zohar · Boston, MAExec · DirectorClayton L. Christopher · Emeryville, CADirectorAlison L. Bauerlein · BOSTON, MADirectorDavid L. Abraham · BOSTON, MAExecAlessandro L. Sannino · BOSTON, MAExecJane L. Wildman · BOSTON, MADirectorDavid Pass · BOSTON, MAExecRaju L. Kucherlapati · BOSTON, MADirectorElaine L. Chiquette · BOSTON, MAExecHarry L. Leider · BOSTON, MAExecDominic L. Perks · BOSTON, MADirectorKathryn L. Cavanaugh · BOSTON, MADirectorYishai Zohar · Boston, MAExec · DirectorPaul L. Fonteyne · BOSTON, MADirectorClayton L. Christopher · Emeryville, CADirectorElliot L. Maltz · BOSTON, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗